We are live on
!
Find out more
IHM
Iguana Healthcare Management Portfolio holdings
AUM
$152M
1-Year Est. Return
48.74%
This Fund
S&P 500
This Quarter
Est. Return
+8.86%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$1.54M
(-1%)
Cap. Flow
+$1.94M
Cap. Flow
% of AUM
1.28%
Top 10 Holdings %
Top 10 Hldgs %
37.96%
Holding
86
New
25
Increased
15
Reduced
14
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
+$4.78M |
| 2 |
SHPG
Shire pic
SHPG
|
+$3.44M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.29M |
| 4 |
Centene
CNC
|
+$3.13M |
| 5 |
Labcorp
LH
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.83M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$5.08M |
| 3 |
AbbVie
ABBV
|
+$4.84M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.77M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$2.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.97% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
26
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.38M | 1.56% |
125,000
-25,000
| -17% | -$534K |
|
27
GSK
GSK
$104B
| $2.34M | 1.54% |
48,000
+24,000
| +100% | +$1.12M |
|
28
Rocket Pharmaceuticals
RCKT
$376M
| $2.34M | 1.54% |
+125,000
| New | +$2.04M |
|
|
MDCO
29
DELISTED
Medicines Co
MDCO
| $2.31M | 1.52% |
70,000
+10,000
| +17% | +$312K |
|
|
ARMO
30
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $2.25M | 1.48% |
+60,000
| New | +$2.52M |
|
31
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.05B
| $2.19M | 1.44% |
+25,000
| New | +$2.27M |
|
|
SRRA
32
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.07M | 1.36% |
25,000
+5,000
| +25% | +$567K |
|
|
DPLO
33
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.02M | 1.33% |
100,000
+50,000
| +100% | +$1.17M |
|
|
MYOK
34
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.95M | 1.28% |
40,000
-10,000
| -20% | -$520K |
|
35
CytomX Therapeutics
CTMX
$788M
| $1.85M | 1.22% |
65,000
-10,000
| -13% | -$285K |
|
36
Iovance Biotherapeutics
IOVA
$2.23B
| $1.69M | 1.11% |
+100,000
| New | +$1.51M |
|
|
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.69M | 1.11% |
+55,000
| New | +$1.53M |
|
38
Karyopharm Therapeutics
KPTI
$216M
| $1.68M | 1.1% |
8,333
-11,667
| -58% | -$2.33M |
|
39
Viking Therapeutics
VKTX
$4.31B
| $1.64M | 1.08% |
375,000
+150,000
| +67% | +$830K |
|
40
Arrowhead Research
ARWR
$10.5B
| $1.44M | 0.95% |
+200,000
| New | +$1.23M |
|
|
MRUS
41
DELISTED
Merus
MRUS
| $1.39M | 0.91% |
75,000
-25,000
| -25% | -$453K |
|
42
Voyager Therapeutics
VYGR
$192M
| $1.31M | 0.87% |
70,000
+20,000
| +40% | +$432K |
|
|
AKAO
43
DELISTED
Achaogen Inc
AKAO
| $1.29M | 0.85% |
100,000
+25,000
| +33% | +$284K |
|
|
CORI
44
DELISTED
Corium International, Inc.
CORI
| $1.26M | 0.83% |
110,000
+20,000
| +22% | +$241K |
|
45
Incyte
INCY
$23.4B
| $1.25M | 0.82% |
15,000
+5,000
| +50% | +$451K |
|
|
CTLT
46
DELISTED
CATALENT, INC.
CTLT
| $1.23M | 0.81% |
30,000
| – | – |
|
|
ADVM
47
DELISTED
Adverum Biotechnologies
ADVM
| $1.16M | 0.76% |
20,000
| – | – |
|
|
CERN
48
DELISTED
Cerner Corp
CERN
| $1.16M | 0.76% |
+20,000
| New | +$1.3M |
|
49
Xencor
XNCR
$1.3B
| $1.05M | 0.69% |
+35,000
| New | +$915K |
|
50
Kura Oncology
KURA
$964M
| $938K | 0.62% |
+50,000
| New | +$973K |
|
Similar funds
HWP
PAM
USG2
LCM
FPF
FIAS
CII
OPWM
Iguana Healthcare Management's Q1 2018 Portfolio in Review
As of Q1 2018, Iguana Healthcare Management held 86 positions worth $152M, down 1% from $154M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Iguana Healthcare Management's Q1 2018 filing shows 25 new, 15 increased, 14 reduced and 24 closed positions. Its largest new stake was Zosano Pharma Corporation: 14,286 shares worth $2.52M. The largest sale was Celgene Corp, an estimated $7.83M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 82% a quarter earlier, followed by Energy.
- Iguana Healthcare Management's largest Q1 2018 buy was Zosano Pharma Corporation: 14,286 shares worth $2.52M.
- Iguana Healthcare Management added most to Arena Pharmaceuticals Inc in Q1 2018, an estimated $1.94M increase.
- Iguana Healthcare Management's biggest Q1 2018 reduction was Esperion Therapeutics, cutting an estimated $4.77M.
- Iguana Healthcare Management fully exited Celgene Corp in Q1 2018, selling an estimated $7.83M.
- Iguana Healthcare Management's ten largest holdings make up 38% of its $152M portfolio in Q1 2018.
- Iguana Healthcare Management opened 25 new positions and closed 24 in Q1 2018.
- Iguana Healthcare Management's portfolio value fell 1% quarter-over-quarter to $152M.
Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.